XML 32 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
OPERATING EXPENSES    
Research and development $ 21,650,840 $ 3,009,027
General and administrative 75,338,256 19,393,141
Total Operating Expense 96,989,096 22,402,168
Loss from Operations (96,989,096) (22,402,168)
Loss on disposal of fixed assets (50,574)  
Other financing costs   (1,559,961)
Gain on extinguishment of indebtedness, net 33,413 890,581
Penalty for insufficient authorized shares (3,495,000)  
Revaluation of warrants liabilities (122,803,715)  
Other financing costs - initial recognition of warrant liabilities (484,421,258)  
Other income (expense), net (5,647,841)  
Interest expense (26,949,081) (21,168,232)
Net Loss before income taxes (740,323,152) (44,239,780)
Provision for income tax (1,600) (800)
Net Loss (740,324,752) (44,240,580)
Net loss attributable to non-controlling interest 791,946  
Net Loss (739,532,806) (44,240,580)
Less: Preferred dividends (40,516,440)  
Net loss attributable to shareholders less preferred dividends $ (780,049,246) $ (44,240,580)
Net Loss per Share, Basic $ (2.80) $ (8.56)
Net Loss per Share, Diluted $ (2.80) $ (8.56)
Weighted average shares outstanding, basic 278,219,500 5,171,144
Weighted average shares outstanding, diluted 278,219,500 5,171,144